医学
内科学
化疗
拓扑替康
置信区间
卵巢癌
优势比
肿瘤科
随机化
无进展生存期
随机对照试验
卡铂
外科
胃肠病学
癌症
顺铂
作者
Kathleen N. Moore,Antoine Angelergues,Gottfried E. Konecny,Yolanda García García,Susana Banerjee,Domenica Lorusso,Jung‐Yun Lee,John W. Moroney,Nicoletta Colombo,A. Roszak,Jacqueline M. Tromp,Tashanna Myers,Jeong‐Won Lee,Mario Beiner,Casey Cosgrove,David Cibula,Lainie P. Martin,Renaud Sabatier,Joseph Buscema,Purificación Estévez-García
标识
DOI：10.1056/nejmoa2309169
摘要
Among participants with platinum-resistant, FRα-positive ovarian cancer, treatment with MIRV showed a significant benefit over chemotherapy with respect to progression-free and overall survival and objective response. (Funded by ImmunoGen; MIRASOL ClinicalTrials.gov number, NCT04209855.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
无极微光
yznfly
Zx_1993
xxfsx
小青椒
Mic
求助人员
淡定绮波
qingmoheng
子车茗
风吹麦田
邓佳鑫Alan
欣喜的秋莲
8R60d8
pcr163
ccm
eric888
ldh
淡淡土豆
寻道图强
zzdd
彭于彦祖
昏睡的蟠桃
皖公网安备34019202002308
